Please assess the completion status of the following clinical trial:

Trial Title: Effect of Bispectral Index (BIS) Titrated Propofol Sedation on Lower Esophageal Sphincter Pressures and Esophageal Function in Intensive Care Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 18-80 years of age~* Written informed consent from relatives~* Clinically stable~* Mechanically ventilated \< 2days~* Require sedation and expected to be given propofol~Exclusion Criteria:~* Recent injury or other pathologic condition of the esophagus~* Major bronchopleural fistula~* History of liver failure~* History of renal failure~* History of major neuromuscular disease~* Multiple trauma~* Upper motor nerve injury~* Hypersensitivity to propofol~* Recent gastrointestinal surgery~* Patients with a diagnosed or suspected condition that may give false results in BIS monitoring.~* Tracheostomized patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- BIS 70 (Type: ACTIVE_COMPARATOR): BIS levels of 70, will be targeted (Anxiolysis/high-frequency EEG activity, beta-augmentation);
- BIS 50 (Type: ACTIVE_COMPARATOR): BIS levels of 50 will be targeted, (Low frequency EEG activity, theta-delta activity)
- BIS 35 (Type: ACTIVE_COMPARATOR): BIS levels of 35 will be targeted (low frequency EEG activity)

Based on this trial design, predict the completion outcome and termination type (if applicable).